The global placenta market is experiencing significant growth, with projections indicating a rise from USD 85.52 billion in 2024 to approximately USD 1,404.87 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.9% during the forecast period.
Market Overview
Placental-derived products have gained prominence across various industries due to their rich composition of bioactive compounds, including growth factors, hormones, and proteins. These components contribute to the therapeutic and cosmetic benefits of placenta-based products, leading to increased adoption in pharmaceuticals, cosmetics, and nutraceutic